Q2 2023 Ocugen Inc Earnings Call Transcript
Good morning and welcome to Ocugen's second-quarter 2023 financial results and business update. Please note that this call is being recorded at this time. (Operator Instructions)
I will now turn the call over to Tiffany Hamilton, Ocugen's Head of Corporate Communications. You may begin.
Thank you, operator. Joining me today are Ocugen's Chairman, CEO, and Co-Founder, Dr. Shankar Musunuri who will provide a business and financial update; and Dr. Arun Upadhyay, our Financial and Scientific Officer, Head of Research, Development and Medical, who is also on the call to answer questions during the Q&A.
Yesterday afternoon, we issued a press release detailing business and operational highlights for the second quarter of 2023. We encourage listeners to review the press release, which is available on our website at ocugen.com. This call is being recorded, and a replay with the accompanying slide presentation will be available on the Investors section of the Ocugen website for
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |